Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 15 , ISSUE 5 ( September-October, 2023 ) > List of Articles

Original Article

Clinico-epidemiological Profile, COVID-19 Vaccination, and Peripartum Outcomes among Pregnant Women in the Third Wave of COVID-19

Sumitra Bachani, Shiwani Tripathi

Keywords : Coronavirus disease-2019 in pregnancy, Coronavirus disease-2019 infection, Pregnancy complications

Citation Information : Bachani S, Tripathi S. Clinico-epidemiological Profile, COVID-19 Vaccination, and Peripartum Outcomes among Pregnant Women in the Third Wave of COVID-19. J South Asian Feder Obs Gynae 2023; 15 (5):550-555.

DOI: 10.5005/jp-journals-10006-2295

License: CC BY-NC 4.0

Published Online: 31-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Introduction: Coronavirus disease 2019 (COVID-19) infection leads to significant morbidity and mortality in women during pregnancy. As seen with other viral diseases in the past, vaccination, currently, is the most-effective eradication method and all pregnant women should be offered COVID-19 vaccination, if no contraindication exists. Despite approval by national and international authorities, many pregnant women are still hesitant to accept the vaccine. Materials and methods: The current study is a retrospective cohort study involving 100 COVID-19 positive pregnant women and 300 negative women who delivered over 3 months. Their demographic, clinical data, vaccination details, and perinatal outcomes were recorded. Results: A low vaccination rate against COVID-19 among pregnant women (26.25%) was reported. A total of 79 (79%) women in COVID-19 and 216 (72%) in non-COVID-19 group were unvaccinated. Most of the women in both groups received Covishield vaccine rather than Covaxin. The most common reasons for not getting the vaccine were unawareness about the vaccination approval in pregnancy (49%) followed by its unknown safety status (10%). Conclusion: The prime barrier to maternal vaccination remains the safety concern associated with the COVID-19 vaccine. Vaccination strategies, when created keeping in mind the attitudes of these priority groups will help increase its uptake during the current pandemic.

PDF Share
  1. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ 2020;370:m3320. DOI: 10.1136/bmj.m3320.
  2. Abdelazim IA, AbuFaza M, Al-Munaifi S. COVID-19 positive woman presented with preterm labor: Case report. Gynecol Obstet Reprod Med 2021;202:1–3. DOI: 10.21613/GORM.2021.1170.
  3. Dey M, Singh S, Tiwari R, et al. Pregnancy outcome in first 50 SARS-CoV-2 positive patients at our center. Gynecol Obstet Reprod Med 2021;27(1):1–6. DOI: 10.21613/GORM.2021.1176.
  4. Centers for Disease Control and Prevention. People with certain medical conditions. Morbidity and Mortality Weekly Report CDC. 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/peoplewith-medical-conditions.html Accessed on: 7 September 2020.
  5. Hinman AR. The eradication of polio: Have we succeeded? Vaccine 2017;35(42):5519–5521. DOI: 10.1016/j.vaccine.2017.09.015.
  6. Durrheim DN, Crowcroft NS, Strebel PM. Measles: The epidemiology of elimination. Vaccine 2014;32(51):6880–6883. DOI: 10.1016/j.vaccine.2014.10.061.
  7. Theiler RN, Wick M, Mehta R, et al. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. Am J Obstet Gynecol MFM 2021;3(6):100467. DOI: 10.1016/j.ajogmf.2021.100467.
  8. Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status – United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69(44): 1641–1647. DOI: 10.15585/mmwr.mm6944e3.
  9. Delahoy MJ, Whitaker M, O'Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 – COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep 2020;69(38): 1347–1354. DOI: 10.15585/mmwr.mm6938e1.
  10. Panagiotakopoulos L, Myers TR, Gee J, et al. SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics – eight U.S. health care centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69(38):1355–1359. DOI: 10.15585/mmwr.mm6938e2.
  11. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status – United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69(25):769–775. DOI: 10.15585/mmwr.mm6925a1.
  12. Douedi S, Miskoff J. Novel coronavirus 2019 (COVID-19): A case report and review of treatments. Medicine (Baltimore) 2020;99(19):e20207. DOI: 10.1097/MD.0000000000020207.
  13. DeBolt CA, Bianco A, Limaye MA, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol 2020;224(5):510.e1–510.e12. DOI: 10.1016/j.ajog.2020.11.022.
  14. Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, et al. Maternal death due to COVID-19. Am J Obstet Gynecol 2020;223(1):109.e1–109.16. DOI: 10.1016/j.ajog.2020.04.030.
  15. Pierce–Williams RAM, Burd J, Felder L, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: A United States cohort study. Am J Obstet Gynecol MFM 2020;2(3):100134. DOI: 10.1016/j.ajogmf.2020.100134.
  16. Juan J, Gil MM, Rong Z, et al. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: Systematic review. Ultrasound Obstet Gynecol 2020;56(1):15–27. DOI: 10.1002/uog.22088.
  17. Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222:521–531. DOI: 10.1016/j.ajog.2020.03.021.
  18. Bloom B, Nowak G, Orenstein W. When will we have a vaccine? Understanding questions and answers about COVID-19 vaccination. N Engl J Med 2020;383(23):2202–2204. DOI: 10.1056/NEJMp2025331.
  19. World Health Organization. 10 global health issues to track in 2021. Available at: https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021. Accessed on: 12 September 2022.
  20. SAGE Working Group on Vaccine Hesitancy. Report of the SAGE Working Group on Vaccine Hesitancy. Available on: https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf. Accessed on: 12 September 2022.
  21. Ayhan S, Oluklu D, Atalay A, et al. COVID-19 vaccine acceptance in pregnant women. Int J Gynecol Obstet 2021;154(2):291–296. DOI: 10.1002/ijgo.13713.
  22. Skjefte M, Ngirbabul M, Akeju O, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: Results of a survey in 16 countries. Eur J Epidemiol 2021;36:197–211. DOI: 10.1007/s10654-021-00728-6.
  23. Centers for Disease Control and Prevention. Local reactions, systemic reactions, adverse events, and serious adverse events: Pfizer–BioNTech COVID-19 vaccine. Available at: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html. Accessed on: 12 September 2022.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.